Bone-Targeting Peptide and RNF146 Modified Apoptotic Extracellular Vesicles Alleviate Osteoporosis

References

• Lorentzon M. Treating osteoporosis to prevent fractures: current concepts and future developments. J Intern Med. 2019;285(4):381–394. doi:10.1111/joim.12873
   PubMed Web of Science ®Google Scholar
• Estell EG, Rosen CJ. Emerging insights into the comparative effectiveness of anabolic therapies for osteoporosis. Nat Rev Endocrinol. 2021;17(1):31–46. doi:10.1038/s41574-020-00426-5
   PubMed Web of Science ®Google Scholar
• Cummings SR, Melton LJ. Epidemiology and outcomes of osteoporotic fractures. Lancet. 2002;359(9319):1761–1767. doi:10.1016/s0140-6736(02)08657-9
   PubMed Web of Science ®Google Scholar
• Song S, Guo Y, Yang Y, Fu D. Advances in pathogenesis and therapeutic strategies for osteoporosis. Pharmacol Ther. 2022;237:108168. doi:10.1016/j.pharmthera.2022.108168
   PubMed Web of Science ®Google Scholar
• Sanchez A, Blanco R. Osteonecrosis of the jaw (ONJ) and atypical femoral fracture (AFF) in an osteoporotic patient chronically treated with bisphosphonates. Osteoporos Int. 2017;28(3):1145–1147. doi:10.1007/s00198-016-3840-z
   PubMed Web of Science ®Google Scholar
• Zhou X, Cornel EJ, Fan Z, He S, Du J. Bone-targeting polymer vesicles for effective therapy of osteoporosis. Nano Lett. 2021;21(19):7998–8007. doi:10.1021/acs.nanolett.1c02150
   PubMed Web of Science ®Google Scholar
• Khan M, Cheung AM, Khan AA. Drug-related adverse events of osteoporosis therapy. Endocrinol Metab Clin North Am. 2017;46(1):181–192. doi:10.1016/j.ecl.2016.09.009
   PubMed Web of Science ®Google Scholar
• Gambrell RD Jr. The menopause: benefits and risks of estrogen-progestogen replacement therapy. Fertil Steril. 1982;37(4):457–474. doi:10.1016/s0015-0282(16)46149-2
   PubMed Web of Science ®Google Scholar
• Xiao Y, Mareddy S, Crawford R. Clonal characterization of bone marrow derived stem cells and their application for bone regeneration. Int J Oral Sci. 2010;2(3):127–135. doi:10.4248/IJOS10045
   PubMed Web of Science ®Google Scholar
• Zimmermann CE, Gierloff M, Hedderich J, Acil Y, Wiltfang J, Terheyden H. Survival of transplanted rat bone marrow-derived osteogenic stem cells in vivo. Tissue Eng Part A. 2011;17(7–8):1147–1156. doi:10.1089/ten.TEA.2009.0577
   PubMed Web of Science ®Google Scholar
• Bergmann A, Steller H. Apoptosis, stem cells, and tissue regeneration. Sci Signal. 2010;3(145):re8. doi:10.1126/scisignal.3145re8
   PubMed Web of Science ®Google Scholar
• Ma L, Chen C, Liu D, et al. Apoptotic extracellular vesicles are metabolized regulators nurturing the skin and hair. Bioact Mater. 2023;19:626–641. doi:10.1016/j.bioactmat.2022.04.022
   PubMed Web of Science ®Google Scholar
• Liu M, Sun Y, Zhang Q. Emerging role of extracellular vesicles in bone remodeling. J Dent Res. 2018;97(8):859–868. doi:10.1177/0022034518764411
   PubMed Web of Science ®Google Scholar
• Poon IKH, Parkes MAF, Jiang L, et al. Moving beyond size and phosphatidylserine exposure: evidence for a diversity of apoptotic cell-derived extracellular vesicles in vitro. J Extracell Vesicles. 2019;8(1):1608786. doi:10.1080/20013078.2019.1608786
   PubMed Web of Science ®Google Scholar
• Tang H, Luo H, Zhang Z, Yang D. Mesenchymal stem cell-derived apoptotic bodies: biological functions and therapeutic potential. Cells. 2022;11(23):3879. doi:10.3390/cells11233879
   PubMed Web of Science ®Google Scholar
• Santavanond JP, Rutter SF, Atkin-Smith GK, Poon IKH. Apoptotic bodies: mechanism of formation, isolation and functional relevance. Subcell Biochem. 2021;97:61–88. doi:10.1007/978-3-030-67171-6_4
   PubMedGoogle Scholar
• Caruso S, Poon IKH. Apoptotic cell-derived extracellular vesicles: more than just debris. Front Immunol. 2018;9:1486. doi:10.3389/fimmu.2018.01486
   PubMed Web of Science ®Google Scholar
• Liu D, Kou X, Chen C, et al. Circulating apoptotic bodies maintain mesenchymal stem cell homeostasis and ameliorate osteopenia via transferring multiple cellular factors. Cell Res. 2018;28(9):918–933. doi:10.1038/s41422-018-0070-2
   PubMed Web of Science ®Google Scholar
• Li M, Xing X, Huang H, et al. BMSC-derived ApoEVs promote craniofacial bone repair via ROS/JNK signaling. J Dent Res. 2022;101(6):714–723. doi:10.1177/00220345211068338
   PubMed Web of Science ®Google Scholar
• Alma Zernecke KB, Noels H, Shagdarsuren E, et al. Delivery of microRNA-126 by apoptotic bodies induces CXCL12-dependent vascular protection. Sci Signal. 2009;2(100):ra81.
   PubMed Web of Science ®Google Scholar
• Li Z, Wu M, Liu S, et al. Apoptotic vesicles activate autophagy in recipient cells to induce angiogenesis and dental pulp regeneration. Mol Ther. 2022;30(10):3193–3208. doi:10.1016/j.ymthe.2022.05.006
   PubMed Web of Science ®Google Scholar
• Ye Q, Xu H, Liu S, et al. Apoptotic extracellular vesicles alleviate Pg-LPS induced inflammatory responses of macrophages via AMPK/SIRT1/NF-kappaB pathway and inhibit osteoclast formation. J Periodontol. 2022;93(11):1738–1751. doi:10.1002/JPER.21-0657
   PubMed Web of Science ®Google Scholar
• Reyes C, Hitz M, Prieto-Alhambra D, Abrahamsen B. Risks and benefits of bisphosphonate therapies. J Cell Biochem. 2016;117(1):20–28. doi:10.1002/jcb.25266
   PubMed Web of Science ®Google Scholar
• Dell RM, Adams AL, Greene DF, et al. Incidence of atypical nontraumatic diaphyseal fractures of the femur. J Bone Miner Res. 2012;27(12):2544–2550. doi:10.1002/jbmr.1719
   PubMed Web of Science ®Google Scholar
• Hatzenbuehler J, Pulling TJ. Diagnosis and management of osteomyelitis. Am Fam Physician. 2011;84(9):1027–1033.
   PubMed Web of Science ®Google Scholar
• Wiklander OP, Nordin JZ, O’Loughlin A, et al. Extracellular vesicle in vivo biodistribution is determined by cell source, route of administration and targeting. J Extracell Vesicles. 2015;4:26316. doi:10.3402/jev.v4.26316
   PubMed Web of Science ®Google Scholar
• Yamashita T, Takahashi Y, Nishikawa M, Takakura Y. Effect of exosome isolation methods on physicochemical properties of exosomes and clearance of exosomes from the blood circulation. Eur J Pharm Biopharm. 2016;98:1–8. doi:10.1016/j.ejpb.2015.10.017
   PubMed Web of Science ®Google Scholar
• Parada N, Romero-Trujillo A, Georges N, Alcayaga-Miranda F. Camouflage strategies for therapeutic exosomes evasion from phagocytosis. J Adv Res. 2021;31:61–74. doi:10.1016/j.jare.2021.01.001
   PubMed Web of Science ®Google Scholar
• Shi C, Wu T, He Y, Zhang Y, Fu D. Recent advances in bone-targeted therapy. Pharmacol Ther. 2020;207:107473. doi:10.1016/j.pharmthera.2020.107473
   PubMed Web of Science ®Google Scholar
• Brown JP, Morin S, Leslie W, et al. Bisphosphonates for treatment of osteoporosis: expected benefits, potential harms, and drug holidays. Cana Family Physician Med Famille Canadien. 2014;60(4):324–333.
   PubMed Web of Science ®Google Scholar
• Drake MT, Clarke BL, Khosla S. Bisphosphonates: mechanism of action and role in clinical practice. Mayo Clin Proc. 2008;83(9):1032–1045. doi:10.4065/83.9.1032
   PubMed Web of Science ®Google Scholar
• Lawson MA, Xia Z, Barnett BL, et al. Differences between bisphosphonates in binding affinities for hydroxyapatite. J Biomed Mater Res B Appl Biomater. 2010;92(1):149–155. doi:10.1002/jbm.b.31500
   PubMedGoogle Scholar
• Khan AA, Morrison A, Hanley DA, et al. Diagnosis and management of osteonecrosis of the jaw: a systematic review and international consensus. J Bone Miner Res. 2015;30(1):3–23. doi:10.1002/jbmr.2405
   PubMed Web of Science ®Google Scholar
• Albert A, Rees CW. Avidity of the tetracyclines for the cations of metals. Nature. 1956;177(4505):433–434. doi:10.1038/177433a0
   PubMed Web of Science ®Google Scholar
• Wang J, Hu J, Zhang S. Studies on the sorption of tetracycline onto clays and marine sediment from seawater. J Colloid Interface Sci. 2010;349(2):578–582. doi:10.1016/j.jcis.2010.04.081
   PubMed Web of Science ®Google Scholar
• Reichert JC, Cipitria A, Epari DR, et al. A tissue engineering solution for segmental defect regeneration in load-bearing long bones. Sci Transl Med. 2012;4(141):141ra93. doi:10.1126/scitranslmed.3003720
   PubMed Web of Science ®Google Scholar
• Valentín S, Morales A, Sánchez JL, Rivera A. Safety and efficacy of doxycycline in the treatment of rosacea. Clin Cosmet Investig Dermatol. 2009;2:129–140. doi:10.2147/ccid.s4296
   PubMedGoogle Scholar
• Rotman SG, Grijpma DW, Richards RG, Moriarty TF, Eglin D, Guillaume O. Drug delivery systems functionalized with bone mineral seeking agents for bone targeted therapeutics. J Control Release. 2018;269:88–99. doi:10.1016/j.jconrel.2017.11.009
   PubMed Web of Science ®Google Scholar
• Zhang G, Guo B, Wu H, et al. A delivery system targeting bone formation surfaces to facilitate RNAi-based anabolic therapy. Nat Med. 2012;18(2):307–314. doi:10.1038/nm.2617
   PubMed Web of Science ®Google Scholar
• Yang YS, Xie J, Wang D, et al. Bone-targeting AAV-mediated silencing of Schnurri-3 prevents bone loss in osteoporosis. Nat Commun. 2019;10(1):2958. doi:10.1038/s41467-019-10809-6
   PubMedGoogle Scholar
• Yang K, Miron RJ, Bian Z, Zhang YF. A bone-targeting drug-delivery system based on Semaphorin 3A gene therapy ameliorates bone loss in osteoporotic ovariectomized mice. Bone. 2018;114:40–49. doi:10.1016/j.bone.2018.06.003
   PubMed Web of Science ®Google Scholar
• Liang C, Guo B, Wu H, et al. Aptamer-functionalized lipid nanoparticles targeting osteoblasts as a novel RNA interference-based bone anabolic strategy. Nat Med. 2015;21(3):288–294. doi:10.1038/nm.3791
   PubMed Web of Science ®Google Scholar
• Ravindran S, Snee PT, Ramachandran A, George A. Acidic domain in dentin phosphophoryn facilitates cellular uptake: implications in targeted protein delivery. J Biol Chem. 2013;288(22):16098–16109. doi:10.1074/jbc.M113.450585
   PubMed Web of Science ®Google Scholar
• Jain S, Deore SV, Ghadi R, Chaudhari D, Kuche K, Katiyar SS. Tumor microenvironment responsive VEGF-antibody functionalized pH sensitive liposomes of docetaxel for augmented breast cancer therapy. Mater Sci Eng C Mater Biol Appl. 2021;121:111832. doi:10.1016/j.msec.2020.111832
   PubMed Web of Science ®Google Scholar
• Maruyama K, Takizawa T, Yuda T, Kennel SJ, Huang L, Iwatsuru M. Targetability of novel immunoliposomes modified with amphipathic poly (ethylene glycol)s conjugated at their distal terminals to monoclonal antibodies. BBA. 1995;1234(1):74–80. doi:10.1016/0005-2736(94)00263-o
   PubMed Web of Science ®Google Scholar
• Zheng C, Sui B, Zhang X, et al. Apoptotic vesicles restore liver macrophage homeostasis to counteract type 2 diabetes. J Extracell Vesicles. 2021;10(7):e12109. doi:10.1002/jev2.12109
   PubMed Web of Science ®Google Scholar
• Ye Q, Qiu X, Wang J, et al. MSCs-derived apoptotic extracellular vesicles promote muscle regeneration by inducing Pannexin 1 channel-dependent creatine release by myoblasts. Int J Oral Sci. 2023;15(1):7. doi:10.1038/s41368-022-00205-0
   PubMed Web of Science ®Google Scholar
• Zhang Y, Liu S, Mickanin C, et al. RNF146 is a poly (ADP-ribose)-directed E3 ligase that regulates axin degradation and Wnt signalling. Nat Cell Biol. 2011;13(5):623–629. doi:10.1038/ncb2222
   PubMed Web of Science ®Google Scholar
• Liao W, Du Y, Zhang C, et al. Exosomes: the next generation of endogenous nanomaterials for advanced drug delivery and therapy. Acta Biomater. 2019;86:1–14. doi:10.1016/j.actbio.2018.12.045
   PubMed Web of Science ®Google Scholar